Related Experiment Videos
Classification and tissue selectivity of calcium antagonists.
1Department of Medicine, University of Melbourne, Austin Hospital, Heidelberg, Australia.
Zeitschrift Fur Kardiologie
|January 1, 1990
Summary
Calcium (Ca2+) antagonists are drugs that reduce Ca2+ flow through specific channels. Tissue selectivity offers a key method for classifying these drugs and assessing their therapeutic value.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Molecular Biology
Background:
- Calcium (Ca2+) antagonists are a diverse class of drugs.
- They inhibit Ca2+ influx via voltage-gated L-type Ca2+ channels.
- Classification relies on multiple criteria, including chemical properties and tissue selectivity.
Purpose of the Study:
- To explore the classification of Ca2+ antagonists.
- To highlight the significance of tissue selectivity in drug classification.
- To understand the basis of tissue selectivity in Ca2+ antagonist action.
Main Methods:
- Review of existing classification criteria for Ca2+ antagonists.
- Analysis of tissue selectivity as a basis for classification.
- Discussion of factors influencing tissue selectivity.
Main Results:
- Six criteria are used for Ca2+ antagonist classification.
- Tissue selectivity is a valuable approach for classification and therapeutic assessment.
- The basis of tissue selectivity is complex, involving drug chemistry and tissue-specific channel subunit composition.
Conclusions:
- Tissue selectivity is a crucial factor in understanding and classifying Ca2+ antagonists.
- Therapeutic usefulness of Ca2+ antagonists can be inferred from their tissue selectivity.
- Further research into the molecular basis of tissue selectivity is warranted.